Insider Transactions in Q2 2025 at Immuneering Corp (IMRX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2025
|
Thomas J. Schall Director |
BUY
Open market or private purchase
|
Direct |
9,500
+15.23%
|
$28,500
$3.66 P/Share
|
|
Jun 23
2025
|
Brett Matthew Hall CHIEF SCIENTIFIC OFFICER |
BUY
Open market or private purchase
|
Direct |
6,007
+1.64%
|
$12,014
$2.43 P/Share
|
|
Jun 20
2025
|
Brett Matthew Hall CHIEF SCIENTIFIC OFFICER |
BUY
Open market or private purchase
|
Direct |
7,415
+2.06%
|
$14,830
$2.7 P/Share
|
|
Jun 20
2025
|
Harold Eugene Brakewood Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
1,900
+24.68%
|
$3,800
$2.53 P/Share
|
|
Jun 18
2025
|
Peter Feinberg Director |
BUY
Open market or private purchase
|
Direct |
25,000
+15.45%
|
$50,000
$2.53 P/Share
|
|
Jun 18
2025
|
Benjamin J. Zeskind PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
21,000
+0.9%
|
$42,000
$2.39 P/Share
|
|
Jun 17
2025
|
Thomas J. Schall Director |
BUY
Open market or private purchase
|
Direct |
40,485
+48.27%
|
$80,970
$2.21 P/Share
|